All Stories

  1. The 2018 ESC/ESH Guidelines for the management of arterial hypertension: A German point of view
  2. OUP accepted manuscript
  3. Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk
  4. Catheter-based renal denervation: the next chapter begins
  5. Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension: state of the art and considerations for the future
  6. Renal denervation: symply trapped by complexity?
  7. Catheter-Based Renal Denervation Is No Simple Matter
  8. Welche kardiale Diagnostik braucht Ihr Hypertoniker?
  9. Renal denervation and heart failure
  10. Novel and Nonpharmacologic Approaches to Cardio-Protection in Hypertension
  11. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial
  12. Renal Artery Denervation
  13. Atrial Autonomic Innervation
  14. Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs
  15. Catheter-Based Renal Denervation
  16. Drug adherence in patients taking oral anticoagulation therapy
  17. Treating resistant hypertension: role of renal denervation
  18. Renal sympathetic denervation: applications in hypertension and beyond
  19. Renal Denervation in the Treatment of Hypertension
  20. The Sympathetic Nervous System in Chronic Kidney Disease
  21. Response and non-response to renal denervation: who is the ideal candidate?
  22. Renal denervation: expanding the indication
  23. Treatment resistant hypertension and renal sympathetic denervation: drug adherence and the consolidation of blood pressure lowering effects
  24. Potential role of renal sympathetic denervation for the treatment of cardiac arrhythmias
  25. Therapeutic potential of renal sympathetic denervation in patients with chronic heart failure
  26. Expanding the indication spectrum: renal denervation in diabetes
  27. Für wen ist sie geeignet?
  28. Catheter-based renal denervation: a word of caution
  29. The Role of Renal Denervation
  30. First-in-human experience: percutaneous renal denervation through a false lumen fenestration in aortic dissection type B
  31. Microalbuminuria independently correlates to cardiovascular comorbidity burden in patients with hypertension
  32. Inadequate Reporting of Concomitant Drug Treatment in Cardiovascular Interventional Head‐to‐Head Trials
  33. Is there a role for renal sympathetic denervation in the future treatment of resistant hypertension?
  34. Sympatho-renal axis in chronic disease
  35. Variability of ventricular repolarization during hypoglycemia
  36. Prognostic electrocardiographic parameters in patients with suspected myocarditis
  37. Hotline sessions and clinical trial updates presented at the European Society of Cardiology Congress in Stockholm 2010
  38. Interventionelle Behandlung der malignen Hypertonie – Pathophysiologie und klinische Daten
  39. From Evidence to Rationale: Cardiovascular Protection by Angiotensin II Receptor Blockers Compared with Angiotensin-Converting Enzyme Inhibitors
  40. Intracranial pressure pulse amplitude during changes in head elevation: a new parameter for determining optimum cerebral perfusion pressure?
  41. The vulnerable myocardium: long-QT syndrome in Tako-Tsubo cardiomyopathy